Takeda Pharmaceutical is an API manufacturer based in Japan. It appears in 28 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with ARCSA (EC) and NMPA (CN). Its GMP standing is certified by MFDS (Korea).
| Molecule | Regulators | Docs |
|---|---|---|
| Azilsartan Medoxomil | SFDA (Saudi Arabia) | 1 |
| Candesartan Cilexetil | SFDA (Saudi Arabia) | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| ARCSA (EC) | 24 | None |
| NMPA (CN) | 4 | None |
| MFDS (Korea) | None | 4 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Takeda Pharmaceutical comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.